CO5280142A1 - VIRAL PARTICLES WITH EXOGENOUS EPITHOPES. . - Google Patents
VIRAL PARTICLES WITH EXOGENOUS EPITHOPES. .Info
- Publication number
- CO5280142A1 CO5280142A1 CO00078905A CO00078905A CO5280142A1 CO 5280142 A1 CO5280142 A1 CO 5280142A1 CO 00078905 A CO00078905 A CO 00078905A CO 00078905 A CO00078905 A CO 00078905A CO 5280142 A1 CO5280142 A1 CO 5280142A1
- Authority
- CO
- Colombia
- Prior art keywords
- exogenous
- epithopes
- viral particles
- capsid
- mfi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un compuesto que comprende una partícula viral quimérica que tiene un cápside, en donde el cápside tiene un lado interior y un lado exterior, el cápside comprendiendo cuando menos un péptido exógeno en el lado interior del cápside.<EMI FILE="00078905_1" ID="1" IMF=JPEG >A compound comprising a chimeric viral particle having a capsid, wherein the capsid has an inner side and an outer side, the capsid comprising at least one exogenous peptide on the inner side of the capsid. <EMI FILE = "00078905_1" ID = "1" MFI = JPEG>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9924352.9A GB9924352D0 (en) | 1999-10-14 | 1999-10-14 | Methods,compositions and applications relating to the generation of novel plant viral particles |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5280142A1 true CO5280142A1 (en) | 2003-05-30 |
Family
ID=10862753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00078905A CO5280142A1 (en) | 1999-10-14 | 2000-10-17 | VIRAL PARTICLES WITH EXOGENOUS EPITHOPES. . |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1235910A1 (en) |
JP (1) | JP2003534771A (en) |
KR (1) | KR100880477B1 (en) |
CN (2) | CN101591647A (en) |
AR (1) | AR026066A1 (en) |
AU (1) | AU785020B2 (en) |
BR (1) | BR0014861A (en) |
CA (1) | CA2387626A1 (en) |
CO (1) | CO5280142A1 (en) |
CZ (1) | CZ20021303A3 (en) |
GB (1) | GB9924352D0 (en) |
IL (1) | IL149077A0 (en) |
MX (1) | MXPA02003789A (en) |
PL (1) | PL354933A1 (en) |
WO (1) | WO2001027282A1 (en) |
ZA (1) | ZA200202815B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000855A2 (en) * | 2001-06-21 | 2003-01-03 | Uab Research Foundation | Chimeric capsid proteins and uses thereof |
US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
MXPA05000287A (en) | 2002-07-05 | 2005-09-08 | Leclerc Denis | Adjuvant viral particle. |
CA2583113C (en) | 2004-10-05 | 2015-11-10 | Diversa Corporation | Compositions comprising an antigen and a promiscuous t-cell epitope |
US20070041999A1 (en) * | 2005-06-01 | 2007-02-22 | Lada Rasochova | Production of multivalent virus like particles |
WO2007011904A2 (en) * | 2005-07-19 | 2007-01-25 | Dow Global Technologies Inc. | Recombinant flu vaccines |
AU2008279584A1 (en) * | 2007-04-27 | 2009-01-29 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
WO2013003353A2 (en) * | 2011-06-30 | 2013-01-03 | Stc.Unm | Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9108386D0 (en) * | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
GB9712282D0 (en) * | 1997-06-12 | 1997-08-13 | Innes John Centre Innov Ltd | Epitope presentation system |
-
1999
- 1999-10-14 GB GBGB9924352.9A patent/GB9924352D0/en not_active Ceased
-
2000
- 2000-10-13 BR BR0014861-0A patent/BR0014861A/en not_active Application Discontinuation
- 2000-10-13 CN CNA2009101426265A patent/CN101591647A/en active Pending
- 2000-10-13 IL IL14907700A patent/IL149077A0/en unknown
- 2000-10-13 EP EP00972153A patent/EP1235910A1/en not_active Withdrawn
- 2000-10-13 KR KR1020027004778A patent/KR100880477B1/en not_active IP Right Cessation
- 2000-10-13 AU AU10852/01A patent/AU785020B2/en not_active Ceased
- 2000-10-13 WO PCT/US2000/028430 patent/WO2001027282A1/en active Application Filing
- 2000-10-13 CN CNA008167532A patent/CN1471580A/en active Pending
- 2000-10-13 CA CA002387626A patent/CA2387626A1/en not_active Abandoned
- 2000-10-13 MX MXPA02003789A patent/MXPA02003789A/en unknown
- 2000-10-13 PL PL00354933A patent/PL354933A1/en unknown
- 2000-10-13 JP JP2001530485A patent/JP2003534771A/en active Pending
- 2000-10-13 CZ CZ20021303A patent/CZ20021303A3/en unknown
- 2000-10-17 CO CO00078905A patent/CO5280142A1/en not_active Application Discontinuation
- 2000-10-17 AR ARP000105455A patent/AR026066A1/en unknown
-
2002
- 2002-04-10 ZA ZA200202815A patent/ZA200202815B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL149077A0 (en) | 2002-11-10 |
KR100880477B1 (en) | 2009-01-28 |
WO2001027282A1 (en) | 2001-04-19 |
KR20020040868A (en) | 2002-05-30 |
CN1471580A (en) | 2004-01-28 |
EP1235910A1 (en) | 2002-09-04 |
PL354933A1 (en) | 2004-03-22 |
JP2003534771A (en) | 2003-11-25 |
AR026066A1 (en) | 2002-12-26 |
MXPA02003789A (en) | 2002-09-30 |
CA2387626A1 (en) | 2001-04-19 |
WO2001027282A8 (en) | 2001-08-16 |
AU1085201A (en) | 2001-04-23 |
AU785020B2 (en) | 2006-08-24 |
GB9924352D0 (en) | 1999-12-15 |
CN101591647A (en) | 2009-12-02 |
CZ20021303A3 (en) | 2002-10-16 |
ZA200202815B (en) | 2003-08-27 |
BR0014861A (en) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USD451046S1 (en) | Ring | |
RU2001129709A (en) | Macrocyclic peptides with activity against hepatitis C virus | |
USD490309S1 (en) | Smoothwall container | |
USD480956S1 (en) | Portion of container | |
ZA200107862B (en) | Macrocyclic peptides active against the hepatitis c virus. | |
CO4960659A1 (en) | VACCINE INCLUDING AN ANTIGEN FOR HEPATITIS B VIRUSES AND AN ANTIGEN FOR HERPES SIMPLEX VIRUS | |
USD485069S1 (en) | Latch for a protective case | |
ES2167374T3 (en) | CONNECTOR TO LOCK AN INTERNAL CANNULA INSIDE AN EXTERNAL CANNULA. | |
CO5160309A1 (en) | ABSORBENT ITEMS THAT HAVE HUMIDITY INDICATOR GRAPHICS INCORPORATING A LEARNING REGION | |
BR9903056B1 (en) | airtight non-metallic composite container. | |
CO5280142A1 (en) | VIRAL PARTICLES WITH EXOGENOUS EPITHOPES. . | |
Lafforgue | A proof of property (RD) for cocompact lattices of SL (3, R) and SL (3, C) | |
EP1003202A3 (en) | Discharge lamp | |
AU7923900A (en) | Retaining net | |
EP1305438A4 (en) | Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) | |
DE60222788D1 (en) | RADAR COUPLING WITH LOW RADAR CROSS SECTION | |
USD517775S1 (en) | Belt | |
DE69738512D1 (en) | EPSTEIN-BARR VIRUS TYPE B CTL EPITOPES | |
USD473009S1 (en) | Reflector for a flashlight | |
USD434325S (en) | Fragrance bottle | |
USD472704S1 (en) | Transportation container | |
USD473510S1 (en) | Equipment carrying case | |
USD436078S1 (en) | Lamp socket | |
USD460502S1 (en) | Paintball tube | |
USD513656S1 (en) | Shorts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |